Revance Therapeutics (RVNC) Return on Equity (ROE) (2014 - 2024)
Revance Therapeutics (RVNC) Return on Equity (ROE) from Mar 31, 2014 to Sep 30, 2024. The TTM Revance Therapeutics (RVNC) Return on Equity (ROE) is 23.38%. You can export chart.
Annual ROE
Quarterly ROE
Annual Return on Equity (ROE) change of Revance Therapeutics (RVNC)
| Year | Return on Equity (ROE) | Change |
|---|---|---|
| 2023 | 213.71% | -107.56% |
| 2022 | -2828.73% | +588.50% |
| 2021 | -410.85% | +445.14% |
| 2020 | -75.37% | +6.59% |
| 2019 | -70.70% | -27.78% |
| 2018 | -97.91% | +118.28% |
| 2017 | -44.85% | -11.03% |
| 2016 | -50.42% | +73.76% |
| 2015 | -29.01% | -18.67% |
| 2014 | -35.68% | N/A |